RHH646 / Novartis - LARVOL DELTA

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=82 | Completed | Sponsor: Novartis Pharmaceuticals | Active, not recruiting ➔ Completed

Trial completion • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=82 | Active, not recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Nov 2025 ➔ Feb 2025 | Trial primary completion date: Nov 2025 ➔ Feb 2025

Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=82 | Active, not recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Feb 2025 ➔ Nov 2025 | Trial primary completion date: Feb 2025 ➔ Nov 2025

Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=82 | Active, not recruiting | Sponsor: Novartis Pharmaceuticals | Recruiting ➔ Active, not recruiting

Enrollment closed • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=78 | Recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Jul 2025 ➔ Feb 2025 | Trial primary completion date: Jul 2025 ➔ Feb 2025

Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=78 | Recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Nov 2025 ➔ Jul 2025 | Trial primary completion date: Nov 2025 ➔ Jul 2025

Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=78 | Recruiting | Sponsor: Novartis Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology • Osteoarthritis • Pain • Rheumatology

Safety and Efficacy of RHH646 for Knee Osteoarthritis (clinicaltrials.gov) - P2 | N=78 | Not yet recruiting | Sponsor: Novartis Pharmaceuticals

New P2 trial • Immunology • Osteoarthritis • Pain • Rheumatology